BioCentury
ARTICLE | Clinical News

Vpriv velaglucerase alfa regulatory update

October 15, 2012 7:00 AM UTC

The Scottish Medicines Consortium recommended the use of Shire's Vpriv velaglucerase alfa on the National Health Service (NHS) in Scotland to treat Type I Gaucher's disease - its approved indication. ...